Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internship and Residency | 9 | 2023 | 1375 | 1.640 |
Why?
|
| Surgeons | 4 | 2023 | 519 | 1.260 |
Why?
|
| Burnout, Professional | 5 | 2021 | 205 | 1.150 |
Why?
|
| Hemangioma | 3 | 2022 | 154 | 1.120 |
Why?
|
| Lymphatic Abnormalities | 3 | 2022 | 29 | 1.100 |
Why?
|
| Education, Medical, Graduate | 6 | 2020 | 671 | 1.070 |
Why?
|
| Splenectomy | 2 | 2015 | 158 | 0.980 |
Why?
|
| Vascular Malformations | 2 | 2022 | 83 | 0.930 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 45 | 0.900 |
Why?
|
| Sirolimus | 2 | 2022 | 814 | 0.800 |
Why?
|
| Colitis, Ulcerative | 2 | 2023 | 268 | 0.690 |
Why?
|
| Ovarian Cysts | 1 | 2019 | 43 | 0.670 |
Why?
|
| Ileostomy | 1 | 2018 | 46 | 0.620 |
Why?
|
| Leadership | 1 | 2020 | 254 | 0.620 |
Why?
|
| Registries | 3 | 2017 | 2170 | 0.620 |
Why?
|
| Infant | 21 | 2023 | 13310 | 0.610 |
Why?
|
| Colectomy | 2 | 2023 | 288 | 0.600 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 290 | 0.580 |
Why?
|
| Hirschsprung Disease | 3 | 2023 | 46 | 0.580 |
Why?
|
| Ovarian Diseases | 1 | 2016 | 54 | 0.570 |
Why?
|
| Torsion Abnormality | 1 | 2016 | 38 | 0.570 |
Why?
|
| Hemangioma, Capillary | 1 | 2015 | 35 | 0.530 |
Why?
|
| Neonatal Screening | 1 | 2015 | 165 | 0.470 |
Why?
|
| Embolization, Therapeutic | 2 | 2016 | 551 | 0.470 |
Why?
|
| Spleen | 1 | 2015 | 676 | 0.450 |
Why?
|
| Postoperative Complications | 6 | 2023 | 5542 | 0.440 |
Why?
|
| Infant, Newborn | 12 | 2023 | 8223 | 0.440 |
Why?
|
| Child | 25 | 2023 | 29154 | 0.430 |
Why?
|
| Hospital Mortality | 3 | 2023 | 1274 | 0.410 |
Why?
|
| Aptamers, Nucleotide | 1 | 2011 | 62 | 0.390 |
Why?
|
| Nephrectomy | 1 | 2015 | 779 | 0.360 |
Why?
|
| Leukemia, Myeloid | 1 | 2014 | 941 | 0.360 |
Why?
|
| General Surgery | 1 | 2013 | 326 | 0.360 |
Why?
|
| Sclerotherapy | 2 | 2022 | 48 | 0.340 |
Why?
|
| Fellowships and Scholarships | 3 | 2023 | 390 | 0.330 |
Why?
|
| Retrospective Studies | 19 | 2023 | 37905 | 0.320 |
Why?
|
| Liver Neoplasms | 2 | 2015 | 4557 | 0.320 |
Why?
|
| Databases, Factual | 6 | 2016 | 2218 | 0.310 |
Why?
|
| Child, Preschool | 13 | 2023 | 16273 | 0.310 |
Why?
|
| Humans | 47 | 2023 | 261506 | 0.310 |
Why?
|
| Myeloproliferative Disorders | 1 | 2014 | 767 | 0.300 |
Why?
|
| Thoracic Duct | 2 | 2016 | 16 | 0.270 |
Why?
|
| Lymphography | 2 | 2016 | 51 | 0.270 |
Why?
|
| Risk Assessment | 2 | 2015 | 6869 | 0.260 |
Why?
|
| Kidney Neoplasms | 2 | 2017 | 3022 | 0.250 |
Why?
|
| Female | 26 | 2023 | 141928 | 0.230 |
Why?
|
| Personal Satisfaction | 2 | 2021 | 140 | 0.230 |
Why?
|
| Job Satisfaction | 2 | 2021 | 122 | 0.220 |
Why?
|
| Adolescent | 12 | 2023 | 31252 | 0.220 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 5687 | 0.220 |
Why?
|
| Colostomy | 1 | 2022 | 70 | 0.220 |
Why?
|
| Enterocolitis | 1 | 2023 | 43 | 0.220 |
Why?
|
| United States | 8 | 2021 | 15433 | 0.220 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2015 | 2326 | 0.220 |
Why?
|
| Accreditation | 2 | 2013 | 126 | 0.210 |
Why?
|
| Pneumothorax | 1 | 2023 | 153 | 0.200 |
Why?
|
| Foreign Bodies | 2 | 2020 | 145 | 0.200 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2014 | 2979 | 0.200 |
Why?
|
| Ultrasonography | 2 | 2019 | 1863 | 0.200 |
Why?
|
| Compassion Fatigue | 1 | 2021 | 3 | 0.200 |
Why?
|
| Reoperation | 2 | 2016 | 1382 | 0.200 |
Why?
|
| Hospitals, Pediatric | 2 | 2016 | 773 | 0.200 |
Why?
|
| Male | 24 | 2023 | 123000 | 0.190 |
Why?
|
| Magnets | 1 | 2020 | 32 | 0.190 |
Why?
|
| Treatment Outcome | 10 | 2023 | 32848 | 0.190 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2021 | 223 | 0.190 |
Why?
|
| Lymphangioma | 1 | 2020 | 36 | 0.190 |
Why?
|
| Neuroblastoma | 2 | 2017 | 686 | 0.190 |
Why?
|
| Appendicitis | 1 | 2022 | 169 | 0.180 |
Why?
|
| Down Syndrome | 1 | 2023 | 226 | 0.180 |
Why?
|
| Hospitals | 1 | 2023 | 485 | 0.180 |
Why?
|
| Parental Leave | 1 | 2019 | 11 | 0.180 |
Why?
|
| Harassment, Non-Sexual | 1 | 2019 | 1 | 0.180 |
Why?
|
| Incivility | 1 | 2019 | 3 | 0.180 |
Why?
|
| Lymphatic Vessels | 1 | 2020 | 143 | 0.170 |
Why?
|
| Prejudice | 1 | 2019 | 57 | 0.170 |
Why?
|
| Constipation | 1 | 2020 | 177 | 0.170 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 4654 | 0.170 |
Why?
|
| Fecal Incontinence | 1 | 2019 | 85 | 0.170 |
Why?
|
| Conservative Treatment | 1 | 2019 | 58 | 0.160 |
Why?
|
| Survival Rate | 4 | 2015 | 12221 | 0.160 |
Why?
|
| Organizational Culture | 1 | 2019 | 106 | 0.160 |
Why?
|
| Career Choice | 1 | 2020 | 232 | 0.160 |
Why?
|
| Medical Errors | 2 | 2021 | 219 | 0.160 |
Why?
|
| Injury Severity Score | 2 | 2016 | 237 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 363 | 0.160 |
Why?
|
| Ontario | 1 | 2018 | 98 | 0.160 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 231 | 0.160 |
Why?
|
| Shorthand | 1 | 2016 | 1 | 0.150 |
Why?
|
| Enterostomy | 1 | 2016 | 6 | 0.150 |
Why?
|
| Intestinal Obstruction | 1 | 2019 | 202 | 0.150 |
Why?
|
| Surgical Stomas | 1 | 2016 | 20 | 0.150 |
Why?
|
| Aggression | 1 | 2019 | 252 | 0.150 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 275 | 0.150 |
Why?
|
| Aircraft | 1 | 2016 | 28 | 0.140 |
Why?
|
| Air Ambulances | 1 | 2016 | 28 | 0.140 |
Why?
|
| Vascular Access Devices | 1 | 2017 | 51 | 0.140 |
Why?
|
| Patient Acuity | 1 | 2016 | 72 | 0.140 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 4314 | 0.140 |
Why?
|
| Chylothorax | 1 | 2016 | 36 | 0.140 |
Why?
|
| Workplace | 1 | 2017 | 76 | 0.140 |
Why?
|
| Incidence | 2 | 2018 | 5673 | 0.140 |
Why?
|
| Patient Handoff | 1 | 2016 | 39 | 0.140 |
Why?
|
| Wounds, Penetrating | 1 | 2016 | 89 | 0.140 |
Why?
|
| Abbreviated Injury Scale | 1 | 2015 | 8 | 0.140 |
Why?
|
| Mentoring | 1 | 2017 | 87 | 0.140 |
Why?
|
| Age of Onset | 1 | 2018 | 827 | 0.130 |
Why?
|
| Head Protective Devices | 1 | 2015 | 26 | 0.130 |
Why?
|
| Bicycling | 1 | 2015 | 38 | 0.130 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 1 | 2015 | 7 | 0.130 |
Why?
|
| Mentors | 1 | 2017 | 203 | 0.130 |
Why?
|
| Algorithms | 2 | 2019 | 3890 | 0.130 |
Why?
|
| Glasgow Coma Scale | 1 | 2015 | 215 | 0.130 |
Why?
|
| Hypoalbuminemia | 1 | 2014 | 46 | 0.130 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 176 | 0.130 |
Why?
|
| Massachusetts | 1 | 2014 | 106 | 0.130 |
Why?
|
| Wilms Tumor | 1 | 2017 | 292 | 0.130 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 213 | 0.130 |
Why?
|
| Device Removal | 1 | 2017 | 337 | 0.130 |
Why?
|
| Vascular Diseases | 1 | 2017 | 246 | 0.120 |
Why?
|
| Pregnancy | 3 | 2023 | 7573 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2013 | 1270 | 0.120 |
Why?
|
| Gestational Age | 2 | 2016 | 1069 | 0.120 |
Why?
|
| Adrenalectomy | 1 | 2015 | 188 | 0.120 |
Why?
|
| Amniotic Fluid | 1 | 2014 | 123 | 0.120 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 830 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 5061 | 0.120 |
Why?
|
| Safety | 1 | 2015 | 465 | 0.110 |
Why?
|
| Leukocyte Count | 1 | 2014 | 684 | 0.110 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 429 | 0.110 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2015 | 172 | 0.110 |
Why?
|
| Insurance, Health | 1 | 2015 | 250 | 0.110 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2015 | 223 | 0.110 |
Why?
|
| Bleomycin | 1 | 2014 | 467 | 0.110 |
Why?
|
| Gadolinium | 1 | 2014 | 164 | 0.110 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 191 | 0.110 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2013 | 42 | 0.110 |
Why?
|
| Medicaid | 1 | 2015 | 279 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 502 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2015 | 291 | 0.100 |
Why?
|
| Physicians | 2 | 2017 | 882 | 0.100 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2013 | 145 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2015 | 583 | 0.100 |
Why?
|
| Ampulla of Vater | 1 | 2013 | 155 | 0.100 |
Why?
|
| Body Weight | 1 | 2016 | 1293 | 0.100 |
Why?
|
| SELEX Aptamer Technique | 1 | 2011 | 5 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 14889 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 2146 | 0.100 |
Why?
|
| Neoplasm Staging | 3 | 2015 | 13658 | 0.100 |
Why?
|
| Schools, Medical | 1 | 2012 | 132 | 0.100 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 4298 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 6207 | 0.100 |
Why?
|
| Patient Transfer | 1 | 2012 | 137 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2014 | 726 | 0.090 |
Why?
|
| Educational Measurement | 1 | 2013 | 362 | 0.090 |
Why?
|
| Spinal Dysraphism | 1 | 2014 | 265 | 0.090 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2015 | 489 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 4892 | 0.090 |
Why?
|
| Endoscopy | 1 | 2013 | 479 | 0.090 |
Why?
|
| Risk Factors | 3 | 2015 | 17523 | 0.090 |
Why?
|
| Anemia | 1 | 2014 | 689 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 1148 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 2403 | 0.080 |
Why?
|
| Comorbidity | 1 | 2015 | 2352 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 998 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 1678 | 0.080 |
Why?
|
| Contrast Media | 1 | 2014 | 1472 | 0.070 |
Why?
|
| Time Factors | 2 | 2018 | 12926 | 0.070 |
Why?
|
| DNA | 1 | 2015 | 2693 | 0.070 |
Why?
|
| Adult | 6 | 2018 | 77950 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 4320 | 0.060 |
Why?
|
| Aged | 5 | 2016 | 70117 | 0.060 |
Why?
|
| Biological Factors | 1 | 2023 | 45 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2015 | 9244 | 0.050 |
Why?
|
| Chest Tubes | 1 | 2023 | 101 | 0.050 |
Why?
|
| Middle Aged | 5 | 2016 | 86204 | 0.050 |
Why?
|
| Public Opinion | 1 | 2023 | 83 | 0.050 |
Why?
|
| Evidence-Based Practice | 1 | 2023 | 117 | 0.050 |
Why?
|
| Quality Improvement | 2 | 2023 | 851 | 0.050 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2023 | 209 | 0.050 |
Why?
|
| Thoracotomy | 1 | 2023 | 220 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 543 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 2330 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 7551 | 0.050 |
Why?
|
| Cloaca | 1 | 2020 | 16 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2020 | 64 | 0.050 |
Why?
|
| Pelvic Floor | 1 | 2020 | 48 | 0.050 |
Why?
|
| Appendectomy | 1 | 2020 | 124 | 0.040 |
Why?
|
| Empathy | 1 | 2021 | 101 | 0.040 |
Why?
|
| Adoption | 1 | 2019 | 14 | 0.040 |
Why?
|
| Intestinal Volvulus | 1 | 2019 | 33 | 0.040 |
Why?
|
| Digestive System Abnormalities | 1 | 2019 | 38 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 2023 | 450 | 0.040 |
Why?
|
| Policy Making | 1 | 2019 | 85 | 0.040 |
Why?
|
| Cysts | 1 | 2020 | 197 | 0.040 |
Why?
|
| Program Development | 1 | 2020 | 261 | 0.040 |
Why?
|
| Patient Safety | 2 | 2016 | 649 | 0.040 |
Why?
|
| Eating | 1 | 2020 | 421 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2019 | 239 | 0.040 |
Why?
|
| Feces | 1 | 2021 | 770 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 665 | 0.040 |
Why?
|
| Colon | 1 | 2021 | 670 | 0.040 |
Why?
|
| Lymphangiectasis | 1 | 2016 | 5 | 0.040 |
Why?
|
| Bronchitis | 1 | 2016 | 38 | 0.040 |
Why?
|
| Punctures | 1 | 2016 | 104 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 597 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2021 | 717 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 2016 | 102 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2016 | 183 | 0.030 |
Why?
|
| Selection Bias | 1 | 2015 | 50 | 0.030 |
Why?
|
| Observer Variation | 1 | 2016 | 671 | 0.030 |
Why?
|
| Mutation | 1 | 2015 | 15179 | 0.030 |
Why?
|
| Intestines | 1 | 2019 | 686 | 0.030 |
Why?
|
| Triage | 1 | 2016 | 252 | 0.030 |
Why?
|
| Accidents, Traffic | 1 | 2015 | 116 | 0.030 |
Why?
|
| Birth Weight | 1 | 2016 | 374 | 0.030 |
Why?
|
| Recurrence | 1 | 2023 | 4758 | 0.030 |
Why?
|
| Cholestasis | 1 | 2016 | 203 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2017 | 500 | 0.030 |
Why?
|
| Health Surveys | 1 | 2015 | 402 | 0.030 |
Why?
|
| Learning | 1 | 2017 | 403 | 0.030 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2015 | 216 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 6009 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2014 | 318 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1559 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 181 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2015 | 521 | 0.030 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 262 | 0.030 |
Why?
|
| North Carolina | 1 | 2012 | 125 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 462 | 0.030 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 423 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 2292 | 0.020 |
Why?
|
| Workload | 1 | 2012 | 198 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2016 | 717 | 0.020 |
Why?
|
| Risk | 1 | 2015 | 1972 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2015 | 1914 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 590 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 4744 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2015 | 2316 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 918 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 2063 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 225 | 0.020 |
Why?
|
| Swine | 1 | 2014 | 1541 | 0.020 |
Why?
|
| Exercise | 1 | 2017 | 1183 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 2231 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 3203 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 12873 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 3441 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 3981 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 6100 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 2803 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 1648 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 4532 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 4988 | 0.020 |
Why?
|
| Transplantation Conditioning | 1 | 2015 | 2238 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 5377 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 2291 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 6086 | 0.020 |
Why?
|
| Communication | 1 | 2012 | 876 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 5112 | 0.020 |
Why?
|
| Young Adult | 1 | 2023 | 21445 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8865 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 4975 | 0.010 |
Why?
|
| Animals | 2 | 2014 | 59536 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 21713 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 7702 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 6550 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 15862 | 0.010 |
Why?
|